Micafungin concentrations 100 mg daily in plasma and burn eschars in patients with severe burn injuries
Critical Care2015Vol. 19(S1)
Alexander Agrifoglio, M. J. Asensio, Manuel Sánchez-Sánchez, Beatriz Galván, E Herrero, L Cachafeiro, Eva Perales, Sònia Luque, Alicia Lorenzo
Abstract
Micafungin (MCF) is an echinocandin agent with broad activity against Candida spp., which are frequently isolated in blood and eschar cultures of burned patients, who present different pharmacokinetics (PK) characteristics. Due to the limited information about its PK, we investigate MCF levels in plasma and burn eschar tissues in this population.
Related Papers
- → Hydrogels for the management of second-degree burns: currently available options and future promise(2022)43 cited
- → Beneficial Effects of Hydron Burn Dressing on Scar Contracture and Wound Healing Following Deep Partial-Thickness Burn Injury(1982)1 cited
- → ANALYSIS OF BURN AND NON-BURN WOUND INFLAMMATORY RESPONSES IN A MURINE MODEL OF INJURY(2006)
- → Wound healing rates on (a) acute burn model (b) excision wound model and the photographs of wound appearance on day 5 after (c) acute burn injury and (d) excision injury.(2015)
- → A histological analysis of burn wound progression(2021)